Connect with us


The director of Overwatch is leaving Blizzard – Yahoo Finance Australia

After nearly two decades at the company, one of Blizzard’s best-known employees is ready for something new.



Article feature image

Opening of Investigational New Drug Application (IND) with U.S. Food and Drug Administration (FDA) for Phase III study of nomacopan in bullous pemphigoid (BP), a severe dermatological disease with no specific approved treatments Phase III study in severe pediatric hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA) is open for enrollment in the U.S. and Europe New data supports potential for nomacopan as a treatment for dry age-related macular degeneration (AMD), a sight-threatening…

Click here to view the original article.

Continue Reading

You might also like ...

Article feature image
This is what Android 12. Google is gearing up for a design revolution – Pakistan Christian TV
Article feature image
It’s time for iPadOS to have its Mac OS X moment – Techradar